Philippines, Indonesia Get Sanofi Cuts In Diabetes, Cancer Drug Prices
This article was originally published in PharmAsia News
Executive Summary
The Philippines and Indonesia have a chance to save as much as 50 percent on the price of some diabetes and cancer drugs produced by France's Sanofi-Aventis